Delivery Order SPE2DB22D2211-SPE2DB25FRNVM

Award Date 1/14/25
Potential Completion Date 1/15/25
Potential Value $1.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,192.88 firm fixed-price delivery order is for the supply of 4,566,552,109 units of Dexmethylphenidate ER 10 mg capsules. The contract has an ultimate completion date of November 27, 2024 and was awarded on November 26, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC)...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,970.48 firm fixed-price delivery order is for the supply of 4,566,178,483 units of dexmethylphenidate ER 30 mg capsules. The contract has an ultimate completion date of October 23, 2024. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the...
The U.S. government's Defense Logistics Agency (DLA) Troop Support Medical awarded a $2,237.10 delivery order contract to Amerisourcebergen Drug Corp's Corporate Office division. The contract is for the supply of 4,565,625,337 units of Dexmethylphenidate ER 10 mg capsules. The contract is a firm fixed-price agreement with an ultimate completion date of August 29, 2024. Amerisourcebergen, a major pharmaceutical distributor, holds a larger Indefinite Delivery Contract (IDC) with DLA Troop...
This federal contract award, valued at $2,033.93, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of dexmethylphenidate ER 10 mg capsules. The contract is a Delivery Order type with a Firm Fixed Price pricing structure, and the ultimate completion date is June 10, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running...
This federal contract award is for the delivery of Dexmethylphenidate ER 10 mg capsules to the Defense Logistics Agency (DLA), a defense agency under the U.S. Department of Defense. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on January 31, 2025 with a ceiling value of $1,576.15. The contract is a Firm Fixed Price Delivery Order with a completion date of February 3, 2025. There is no set-aside designation for this...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 4,563,852,096 units of Dexmethylphenidate ER 10 mg capsules. The contract has a potential value of $3,189.84 and a completion date of March 5, 2024. Amerisourcebergen Drug Corp is the prime contractor on this award, which is not designated as a set-aside. This delivery order falls under a larger, single award indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp. The $2,914.62 firm fixed-price delivery order is for the supply of 4,566,338,436 units of the medication dexmethylphenidate ER 5 mg capsules. The contract has an ultimate completion date of November 6, 2024. Amerisourcebergen, a major pharmaceutical distributor and healthcare solutions provider, holds a $999,999,999 Indefinite Delivery Contract...
The federal contract award summarized is for the delivery of 4,565,943,853 units of Dexmethylphenidate ER 20 mg capsules. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for a firm fixed price of $2,338.84. The contract is a delivery order with an ultimate completion date of September 26, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award from the Defense Logistics Agency (DLA) was made to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,566,614,092 units of Dexmethylphenidate ER 15 mg capsules. The Firm Fixed Price contract, valued at $1,149.58, has an ultimate completion date of December 5, 2024. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp is the prime contractor, and the contract is part of the company's larger Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a global pharmaceutical sourcing and distribution company. The $1,202.80 firm fixed price delivery order is for the supply of 4,563,943,950 units of the medication Dexmethylphenidate ER 10 mg capsules. The award does not have a set-aside designation. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA, valued at...
  • SPE2DB22D2211
    Indefinite Delivery Contract
  • SPE2DB22D2211-SPE2DB25FRNVM
    Delivery Order

This federal contract award, issued by the Defense Logistics Agency (DLA), is a delivery order for Dexmethylphenidate ER 10 mg capsules to be delivered by the prime contractor, Amerisourcebergen Drug Corp. The $1,405.56 firm-fixed-price contract has a performance period through January 15, 2025. Amerisourcebergen, a major pharmaceutical distributor, holds an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 through November 2026, which serves as the primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This specific delivery order is not designated as a set-aside contract.

Generated 5/21/25, 10:23 AM